CRNX
Overvalued by 115.4% based on the discounted cash flow analysis.
Market cap | $3.27 Billion |
---|---|
Enterprise Value | $3.00 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-3.69 |
Beta | 0.62 |
Outstanding Shares | 80,091,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -10.15 |
---|---|
PEG | -30.1 |
Price to Sales | - |
Price to Book Ratio | 3.55 |
Enterprise Value to Revenue | 2889.55 |
Enterprise Value to EBIT | -9.75 |
Enterprise Value to Net Income | -11 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.07 |
No data
No data